Brief: Tianjin Development Posts HY Net Profit Attributable Of RMB342.9 Million For Tianjin Lisheng Pharmaceutical
22/08/2025 05:05
Aug 22 (Reuters) - Tianjin Lisheng Pharmaceutical Co Ltd 002393.SZ: HY NET PROFIT ATTRIBUTABLE RMB342.9 MILLION FOR TIANJIN LISHENG PHARMACEUTICAL HY TOTAL OPERATING INCOME RMB731.5 MILLION FOR TIANJIN LISHENG PHARMACEUTICAL Further company coverage: 002393.SZ ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln